PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2012

Beta-adrenergic receptor inhibition affects cerebral glucose metabolism, motor performance, and inflammatory response after traumatic brain injury.

Mouse / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 22743370 ↗2012Reported benefit

Beta-adrenergic receptor inhibition affects cerebral glucose metabolism, motor performance, and inflammatory response after traumatic brain injury.

MouseTBIUnspecifiedC57BL/6, with beta1/beta2-adrenergic receptor knockout (BARKO) miceMaleTail vein injection4 mg/kgAfter traumatic brain injury

Model: Traumatic brain injury in mice, with sham injury controls

Cerebral glucose metabolism fell after injury (mean SUV 1.63 versus sham 1.97, p less than 0.01) and propranolol attenuated this reduction (1.89 versus 1.63, p less than 0.01). Propranolol and receptor knockout both reduced motor deficits at 24 h, with rotarod 44 versus 23 seconds and rearing 338 v…

Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.